Industrifonden strengthens its Life Science investment team by recruiting Jonas Jendi as new Investment Manager. Jonas has extensive experience in leading and developing start-ups from research phase to exit and global expansion, as well as from analyst roles and serving on the board of various public companies.
– Jonas’ extensive experience from the life science industry makes him a valuable addition to our team, says Nina Rawal, Head of Life Science at Industrifonden.
Jonas Jendi started his career at the Boston Consulting Group and has more than 15 years of experience from the field of life science. He has held the role as CEO of Cogmed Systems AB, and was part of the journey from VC-financed startup to buyout and integration into Pearson Inc, where he held positions as Vice President and General Manager at Pearson Clinical Assessments in the US. After returning home from the US, he has held various positions in the Swedish life science sector as well as serving on the board of companies as BioInvent and Diamyd.
Jonas will, until end of April, be a contributor to Svenska Dagbladet´s service SvD Börsplus, supplying equity analysis of public life science companies.
– I have, from diverse perspectives, witnessed the importance of experienced, risk willing and sustainable venture capital for new and innovative companies within life science. Therefore, I look forward to being part of the Life Science team at Industrifonden who stands for those values, and represents a very exciting investment portfolio, says Jonas Jendi who begins as Investment Manager on May 15.